Literature DB >> 3932886

Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes.

M G Zelechowska, J A van Mourik, T Brodniewicz-Proba.   

Abstract

Factor VIII is generally believed to circulate in blood as a multimeric complex of two glycoproteins which are physiologically and immunologically distinct. One component of the factor VIII complex is factor VIII procoagulant activity (FVIII:C) which is associated with factor VIII/procoagulant antigen (FVIII:Ag, formerly FVIII/CAg). The second, larger unit of the complex is factor VIII/von Willebrand factor (vWF:Ag, formerly factor VIII-related antigen or FVIIIRAg). FVIII:C has anti-haemophilic activity and is defective or deficient in patients with classical haemophilia, and vWF:Ag is absent in patients with von Willebrand disease. FVIII:Ag was demonstrated recently in endothelial cells lining hepatic sinusoids, by using immunoperoxidase staining and light microscopy, whereas biochemical data had indicated its presence predominantly in the hepatocyte fractions and in lesser amounts in endothelial cells. Moreover, recent hybridization experiments detected FVIII:C messenger RNA in liver and kidney tissues. Despite several efforts, the cells responsible for FVIII:C synthesis have not been unequivocally identified. Here we use protein A-gold complex labelling to demonstrate the ultrastructural localization of FVIII:C in human liver cells; the results indicate that hepatocytes may synthesize FVIII:Ag.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932886     DOI: 10.1038/317729a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

Review 1.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Isolation and culture of cells derived from human cerebral microvessels.

Authors:  H V Vinters; S Reave; P Costello; J P Girvin; S A Moore
Journal:  Cell Tissue Res       Date:  1987-09       Impact factor: 5.249

Review 3.  Cell biology of liver endothelial and Kupffer cells.

Authors:  B Smedsrød; P J De Bleser; F Braet; P Lovisetti; K Vanderkerken; E Wisse; A Geerts
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

Review 4.  Desmopressin (DDAVP) and hemostasis.

Authors:  S Lethagen
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

5.  Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs.

Authors:  Chul-Yong Park; Jungeun Kim; Jiyeon Kweon; Jeong Sang Son; Jae Souk Lee; Jeong-Eun Yoo; Sung-Rae Cho; Jong-Hoon Kim; Jin-Soo Kim; Dong-Wook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

6.  Murine coagulation factor VIII is synthesized in endothelial cells.

Authors:  Lesley A Everett; Audrey C A Cleuren; Rami N Khoriaty; David Ginsburg
Journal:  Blood       Date:  2014-04-09       Impact factor: 22.113

Review 7.  Progress and challenges in the development of a cell-based therapy for hemophilia A.

Authors:  M E Fomin; P P Togarrati; M O Muench
Journal:  J Thromb Haemost       Date:  2014-10-31       Impact factor: 5.824

8.  Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

Authors:  J B Rosenberg; P A Foster; R J Kaufman; E A Vokac; M Moussalli; P A Kroner; R R Montgomery
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

9.  Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; M V Davies; R J Wise; D I Israel; A J Dorner
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

10.  Delivery of factor VIII gene into skeletal muscle cells using lentiviral vector.

Authors:  Hyun Jeong Jeon; Tae Keun Oh; Oak Hee Kim; Seung Taik Kim
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.